EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieVergleichsstudieOpen Access · CC BY 4.0

Comparable efficacy of extraoral and intraoral photobiomodulation in preventing oral mucositis during high-dose methotrexate therapy in pediatric oncology: A single-blind randomized controlled trial

Isabela de Oliveira Plugge Freitas iD, Isabela Schuartz, Giovanna Leal Klein Renz, Rafael Zancan Mobile, Mariana Lena Sassi França, Mara Albonei Dudeque Pianovski, Laurindo Moacir Sassi, Melissa Rodrigues de Araujo

Supportive Care in Cancer · 2026-11 · 34 (11)

DOI: 10.1007/s00520-026-11372-9 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Supportive Care in Cancer, online erschienen am 19.10.2026. Verfasst von Isabela de Oliveira Plugge Freitas und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Stomatology, Federal University of Paraná (UFPR), Curitiba, Paraná, Brazil. isaopf@gmail.com. Hauptthemen laut MEDLINE: Stomatitis, Methotrexate, Low-Level Light Therapy, Antimetabolites, Antineoplastic. Die Arbeit nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

This prospective randomized controlled clinical study compared intraoral (IO) and extraoral (EO) photobiomodulation (PBM) for the prevention of chemotherapy-induced oral mucositis (OM) in pediatric oncology patients.

Methods

A total of 155 patients (1–18 years), receiving high-dose methotrexate (HDMTX) for leukemia, lymphoma, or osteosarcoma, were randomized to PBM-IO ( n = 73) or PBM-EO ( n = 82). Preventive PBM was administered daily from hospital admission through discharge. Both protocols used red light with equivalent dosimetry (660 nm, 100 mW, 1 J per point). PBM-EO required 30 s/session, whereas PBM-IO required approximately 6 min, excluding patient handling time. OM occurrence, severity (WHO scale), plaque index, and pain (numeric rating scale) were assessed on days 0, 3, 5, and 10 after HDMTX infusion.

Results

The overall OM occurrence was 35.5%, with no significant difference between PBM-IO (41.1%) and PBM-EO (30.5%) groups ( p = 0.168). No statistically significant differences were observed between groups for OM severity, pain, salivary pH, or plaque index at any time point ( p > 0.05). Multivariable ordinal logistic regression demonstrated that PBM modality was not independently associated with OM severity. As expected, increasing age (OR = 1.14; 95% CI: 1.04–1.25; p = 0.004) and higher HDMTX dose (OR = 1.24; 95% CI: 1.03–1.49; p = 0.021) were significantly associated with greater OM severity. Median pain scores remained 0 at all assessment points in both groups.

Conclusion

Extraoral PBM demonstrated comparable effectiveness to intraoral for OM prevention in pediatric patients undergoing HDMTX chemotherapy, while reducing application time.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

StomatitisMethotrexateLow-Level Light TherapyAntimetabolites, AntineoplasticHumansAdolescentFemaleChildMaleChild, PreschoolProspective StudiesSingle-Blind MethodInfantRed LightSeverity of Illness IndexNeoplasmsPain Measurement

Stichwörter der Autor:innen

Low-level light therapyMedical oncologyMethotrexateOral medicineOral mucositisPediatrics

Substanzen

MethotrexateAntimetabolites, Antineoplastic

Autor:innen und Institutionen

  • Department of Stomatology, Federal University of Paraná (UFPR), Curitiba, Paraná, Brazil. isaopf@gmail.com.
  • Department of Stomatology, Federal University of Paraná (UFPR), Curitiba, Paraná, Brazil.
  • Hospital Erasto Gaertner, Curitiba, Paraná, Brazil.
  • National Institute of Science and Technology in Translational Biophotonics in Dentistry, INCT-BIOFOTO BUCAL, Porto Alegre, Brazil.

ORCID-Profile: Isabela de Oliveira Plugge Freitas

Zitieren

APA

Freitas, I. O. P., Schuartz, I., Renz, G. L. K., Mobile, R. Z., França, M. L. S., Pianovski, M. A. D., Sassi, L. M., & de Araujo, M. R. (2026). Comparable efficacy of extraoral and intraoral photobiomodulation in preventing oral mucositis during high-dose methotrexate therapy in pediatric oncology: A single-blind randomized controlled trial. Supportive Care in Cancer, 34(11). https://doi.org/10.1007/s00520-026-11372-9

Vancouver

Freitas IOP, Schuartz I, Renz GLK, Mobile RZ, França MLS, Pianovski MAD, et al. Comparable efficacy of extraoral and intraoral photobiomodulation in preventing oral mucositis during high-dose methotrexate therapy in pediatric oncology: A single-blind randomized controlled trial. Supportive Care in Cancer. 2026;34(11). doi:10.1007/s00520-026-11372-9

BibTeX
@article{Freitas2026,
  author = {Freitas, Isabela de Oliveira Plugge and Schuartz, Isabela and Renz, Giovanna Leal Klein and Mobile, Rafael Zancan and França, Mariana Lena Sassi and Pianovski, Mara Albonei Dudeque and Sassi, Laurindo Moacir and de Araujo, Melissa Rodrigues},
  title = {Comparable efficacy of extraoral and intraoral photobiomodulation in preventing oral mucositis during high-dose methotrexate therapy in pediatric oncology: A single-blind randomized controlled trial},
  journal = {Supportive Care in Cancer},
  year = {2026},
  volume = {34},
  number = {11},
  doi = {10.1007/s00520-026-11372-9}
}
Kostenlos starten →